• 1
    Nadler RB, Humphrey PA, Smith DS et al. Effect of inflammation and BPH on elevated PSA levels. J Urol 1995; 154: 40713
  • 2
    Catalona WJ, Miller DR, Kavoussi LR. Intermediate term survival results in clinically understaged prostate cancer patients following radical prostatectomy. J Urol 1988; 140: 5403
  • 3
    Catalona WJ, Richie JP, Ahmaan FR et al. Comparison of digital rectal examination and serum PSA in the early detection of prostate cancer: results of a multicentre clinical trial of 6,630 men. J Urol 1994; 151: 128390
  • 4
    Schroder FH, Wildhagen MF. Screening for prostate cancer. evidence and perspective. BJU Int 2001; 88: 8117
  • 5
    Christensson A, Bjork T, Nilsson O et al. Serum PSA complexed to alpha-1-anti-chymotrypsin as an indicator of prostate cancer. J Urol 1993; 150: 1005
  • 6
    Memon A, Al-Muhanna AN. Annual cancer incidence in Kuwaitis 1992–93. In ParkinDM, WhelanSL, FerlayJ et al. eds. Cancer Incidence in Five Continents, Vol. VIII. no. 143. Lyons, France: IARC Scientific Publications, 1997: 4107
  • 7
    Kehinde EO. Prostate cancer in the Middle East: Perspective from Oman. In BelldegrunA, KirbyRS, OliverRTD eds. New Perspectives in Prostate Cancer. Oxford: ISIS Medical Media, 1998: 38390
  • 8
    Hanash KA, Al-Othmaimen A, Kattan S et al. Prostatic carcinoma. A nutritional disease? Conflicting data from the Kingdom of Saudi Arabia. J Urol 1999; 161: 71
  • 9
    Anim JT, Udo S, John B. Characterisation of inflammatory cells in benign prostatic hyperplasia. Acta Histochem 1998; 100: 43999
  • 10
    Nickel JC, True LD, Kreiger IN, Berger RE, Boag AH, Young ID. Consensus development of a histopathological classification system for chronic prostatic inflammation. BJU Int 2001; 87: 797805
  • 11
    Selmy G. The value of TRUS in the ultrasonographic unit. Afr J Urol 1998; 4: 937
  • 12
    Toktas G, Unluer E, Aglamis E, Kulksizoglu H, Mimaroglu S. Effects of chronic prostatitis on prostate specific antigen. BJU Int 2000; 86 (Suppl. 3): 104
  • 13
    Tan YH, Tan KY, Foo KT. The role of a trial of antibiotics in asymptomatic patients with elevated prostate specific antigen – an Asian Perspective. BJU Int 2000; 86 (Suppl. 3): 104
  • 14
    Hasui Y, Marutsuka K, Asada Y, Ide H, Nishi S, Osada Y. Relationship between serum prostate specific antigen and histological prostatitis in patients with benign prostatic hyperplasia. The Prostate 1994; 25: 916
  • 15
    Dalton DL. Elevated serum prostate specific antigen due to acute bacterial prostatitis. Urology 1989; 33: 4656
  • 16
    Neal DE Jr, Clejan S, Sarma D, Moon TD. Prostate specific antigen and prostatitis I. Effect of prostatitis on serum PSA in the human and non-human primate. The Prostate 1992; 20: 10510
  • 17
    Anim JT, Ebrahim BH, Sathar SA. Benign disorders of the prostate: a histological study. Ann Saudi Med 1998; 18: 227
  • 18
    Stewart CS, Leibovich BC, Weaver AL, Lieber MA. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J Urol 2001; 166: 8691
  • 19
    Stamey TA. Editorial comment: saturation prostate needle biopsy. J Urol 2001; 166: 912
  • 20
    Durgan JA, Bostwick DG, Myers RP et al. The definition and preoperative prediction of clinically insignificant prostate cancer JAMA 1996; 275: 28894